-
Araki K, Youngblood B, Ahmed R, 2010: The role of mTOR in memory CD8 T-cell differentiation[J]. Immunol Rev, 235, 234-243. doi: 10.1111/j.0105-2896.2010.00898.x
-
Betz C, Hall MN, 2013: Where is mTOR and what is it doing there?[J]. J Cell Biol, 203, 563-574. doi: 10.1083/jcb.201306041
-
Bossler F, Hoppe-Seyler K, Hoppe-Seyler F, 2019: PI3K/AKT/mTOR signaling regulates the virus/host cell crosstalk in HPV-positive cervical cancer cells[J]. Int J Mol Sci, 20, 2188-. doi: 10.3390/ijms20092188
-
Cao W, Manicassamy S, Tang H, Kasturi SP, Pirani A, Murthy N, Pulendran B, 2008: Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway[J]. Nat Immunol, 9, 1157-1164. doi: 10.1038/ni.1645
-
Cha MY, Kim CM, Park YM, Ryu WS, 2004: Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells[J]. Hepatology, 39, 1683-1693. doi: 10.1002/hep.20245
-
Chan C, Thurnherr T, Wang J, Gallart-Palau X, Sze SK, Rozen S, Lee CG, 2016: Global re-wiring of p53 transcription regulation by the hepatitis B virus X protein[J]. Mol Oncol, 10, 1183-1195. doi: 10.1016/j.molonc.2016.05.006
-
Chan C, Wang Y, Chow PK, Chung AY, Ooi LL, Lee CG, 2013: Altered binding site selection of p53 transcription cassettes by hepatitis B virus X protein[J]. Mol Cell Biol, 33, 485-497. doi: 10.1128/MCB.01189-12
-
Chen M, Lu J, Wei W, Lv Y, Zhang X, Yao Y, Wang L, Ling T, Zou X, 2018: Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1alpha signaling pathway through TSC1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo[J]. Onco Targets Ther, 11, 6705-6722. doi: 10.2147/OTT.S161198
-
Chen X, Hu Y, Zhang W, Chen K, Hu J, Li X, Liang L, Cai X, Hu J, Wang K, Huang A, Tang N, 2019: Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway[J]. Free Radic Biol Med, 131, 225-236. doi: 10.1016/j.freeradbiomed.2018.12.008
-
Cheng X, Wang Y, Tian J, Zhou L, Chen X, Guo H, Zeng J, Shen N, Li J, Ke J, Zhu Y, Gong J, Chang J, Liu L, Zhong R, 2019: SLC10A1 S267F variant influences susceptibility to HBV infection and reduces cholesterol level by impairing bile acid uptake[J]. J Viral Hepat, 26, 1178-1185. doi: 10.1111/jvh.13157
-
Choi YM, Lee SY, Kim BJ, 2019: Naturally occurring hepatitis B virus mutations leading to endoplasmic reticulum stress and their contribution to the progression of hepatocellular carcinoma[J]. Int J Mol Sci, 20, 597-. doi: 10.3390/ijms20030597
-
Chung TW, Lee YC, Kim CH, 2004: Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential[J]. FASEB J, 18, 1123-1125. doi: 10.1096/fj.03-1429fje
-
Chung TW, Lee YC, Ko JH, Kim CH, 2003: Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells[J]. Cancer Res, 63, 3453-3458.
-
Ciuffreda L, Di Sanza C, Incani UC, Milella M, 2010: The mTOR pathway: a new target in cancer therapy[J]. Curr Cancer Drug Targets, 10, 484-495. doi: 10.2174/156800910791517172
-
Claus C, Liebert UG, 2014: A renewed focus on the interplay between viruses and mitochondrial metabolism[J]. Arch Virol, 159, 1267-1277. doi: 10.1007/s00705-013-1841-1
-
Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P, 2007: mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex[J]. Nature, 450, 736-740. doi: 10.1038/nature06322
-
Daud M, Rana MA, Husnain T, Ijaz B, 2017: Modulation of Wnt signaling pathway by hepatitis B virus[J]. Arch Virol, 162, 2937-2947. doi: 10.1007/s00705-017-3462-6
-
Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, Worley PF, Kozma SC, Powell JD, 2009: The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment[J]. Immunity, 30, 832-844. doi: 10.1016/j.immuni.2009.04.014
-
Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, Xiao B, Worley PF, Powell JD, 2011: The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2[J]. Nat Immunol, 12, 295-303.
-
Duvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, Vander Heiden MG, MacKeigan JP, Finan PM, Clish CB, Murphy LO, Manning BD, 2010: Activation of a metabolic gene regulatory network downstream of mTOR complex 1[J]. Mol Cell, 39, 171-183. doi: 10.1016/j.molcel.2010.06.022
-
Eaton HE, Saffran HA, Wu FW, Quach K, Smiley JR, 2014: Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity[J]. J Virol, 88, 7379-7388. doi: 10.1128/JVI.00712-14
-
Efeyan A, Zoncu R, Sabatini DM, 2012: Amino acids and mTORC1: from lysosomes to disease[J]. Trends Mol Med, 18, 524-533. doi: 10.1016/j.molmed.2012.05.007
-
Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J, 2001: Phosphatidic acid-mediated mitogenic activation of mTOR signaling[J]. Science, 294, 1942-1945. doi: 10.1126/science.1066015
-
Fanning GC, Zoulim F, Hou J, Bertoletti A, 2019: Therapeutic strategies for hepatitis B virus infection: towards a cure[J]. Nat Rev Drug Discov, 18, 827-844. doi: 10.1038/s41573-019-0037-0
-
Feng Z, Zhang H, Levine AJ, Jin S, 2005: The coordinate regulation of the p53 and mTOR pathways in cells[J]. Proc Natl Acad Sci U S A, 102, 8204-8209. doi: 10.1073/pnas.0502857102
-
Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, Teague JW, Campbell PJ, Stratton MR, Futreal PA, 2011: COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer[J]. Nucleic Acids Res, 39, D945-950. doi: 10.1093/nar/gkq929
-
Geier A, 2014: Hepatitis B virus: the "metabolovirus" highjacks cholesterol and bile acid metabolism[J]. Hepatology, 60, 1458-1460. doi: 10.1002/hep.27224
-
Gish RG, Given BD, Lai CL, Locarnini SA, Lau JY, Lewis DL, Schluep T, 2015: Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities[J]. Antiviral Res, 121, 47-58. doi: 10.1016/j.antiviral.2015.06.008
-
Glebe D, Bremer CM, 2013: The molecular virology of hepatitis B virus[J]. Semin Liver Dis, 33, 103-112. doi: 10.1055/s-0033-1345717
-
Groenewoud MJ, Zwartkruis FJ, 2013: Rheb and Rags come together at the lysosome to activate mTORC1[J]. Biochem Soc Trans, 41, 951-955. doi: 10.1042/BST20130037
-
Guo H, Jiang D, Zhou T, Cuconati A, Block TM, Guo JT, 2007a: Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation[J]. J Virol, 81, 12472-12484. doi: 10.1128/JVI.01123-07
-
Guo H, Zhou T, Jiang D, Cuconati A, Xiao GH, Block TM, Guo JT, 2007b: Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway[J]. J Virol, 81, 10072-10080. doi: 10.1128/JVI.00541-07
-
Guo Z, Cheng X, Feng X, Zhao K, Zhang M, Yao R, Chen Y, Wang Y, Hao H, Wang Z, 2019: The mTORC1/4EBP1/PPARgamma axis mediates insulin-induced lipogenesis by regulating lipogenic gene expression in bovine mammary epithelial cells[J]. J Agric Food Chem, 67, 6007-6018. doi: 10.1021/acs.jafc.9b01411
-
Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ, 2008: AMPK phosphorylation of raptor mediates a metabolic checkpoint[J]. Mol Cell, 30, 214-226. doi: 10.1016/j.molcel.2008.03.003
-
Han J, Li E, Chen L, Zhang Y, Wei F, Liu J, Deng H, Wang Y, 2015: The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1[J]. Nature, 524, 243-246. doi: 10.1038/nature14557
-
Hay N, Sonenberg N, 2004: Upstream and downstream of mTOR[J]. Genes Dev, 18, 1926-1945. doi: 10.1101/gad.1212704
-
He L, Zang A, Du M, Ma D, Yuan C, Zhou C, Mu J, Shi H, Li D, Huang X, Deng Q, Xiao J, Yan H, Hui L, Lan K, Xiong S, Li X, Huang Z, Xiao H, 2015: mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines[J]. Virol Sin, 30, 174-189. doi: 10.1007/s12250-015-3606-3
-
He Q, Song X, Huang Y, Huang W, Ye B, Luo H, Luo H, Wu L, Wang Z, Chen W, Zhang L, 2018: Dexamethasone stimulates hepatitis B virus (HBV) replication through autophagy[J]. Med Sci Monit, 24, 4617-4624. doi: 10.12659/MSM.906250
-
Huang W, Zhao F, Huang Y, Li X, Zhu S, Hu Q, Chen W, 2014: Rapamycin enhances HBV production by inducing cellular autophagy[J]. Hepat Mon, 14, e20719-.
-
Hung JH, Su IJ, Lei HY, Wang HC, Lin WC, Chang WT, Huang W, Chang WC, Chang YS, Chen CC, Lai MD, 2004: Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase[J]. J Biol Chem, 279, 46384-46392. doi: 10.1074/jbc.M403568200
-
Inoki K, Li Y, Xu T, Guan KL, 2003a: Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling[J]. Genes Dev, 17, 1829-1834. doi: 10.1101/gad.1110003
-
Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, Wang CY, He X, MacDougald OA, You M, Williams BO, Guan KL, 2006: TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth[J]. Cell, 126, 955-968. doi: 10.1016/j.cell.2006.06.055
-
Inoki K, Zhu T, Guan KL, 2003b: TSC2 mediates cellular energy response to control cell growth and survival[J]. Cell, 115, 577-590. doi: 10.1016/S0092-8674(03)00929-2
-
Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, Hall MN, 2004: Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive[J]. Nat Cell Biol, 6, 1122-1128. doi: 10.1038/ncb1183
-
Jager S, Handschin C, St-Pierre J, Spiegelman BM, 2007: AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha[J]. Proc Natl Acad Sci U S A, 104, 12017-12022. doi: 10.1073/pnas.0705070104
-
Ji WT, Liu HJ, 2008: PI3K-Akt signaling and viral infection[J]. Recent Pat Biotechnol, 2, 218-226. doi: 10.2174/187220808786241042
-
Karayiannis P, 2017: Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread[J]. Hepatol Int, 11, 500-508. doi: 10.1007/s12072-017-9829-7
-
Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM, 2002: mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery[J]. Cell, 110, 163-175. doi: 10.1016/S0092-8674(02)00808-5
-
Kim J, Kundu M, Viollet B, Guan KL, 2011: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1[J]. Nat Cell Biol, 13, 132-141. doi: 10.1038/ncb2152
-
Kim K, Kim KH, Kim HH, Cheong J, 2008: Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha[J]. Biochem J, 416, 219-230. doi: 10.1042/BJ20081336
-
Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, Kim HH, Yang US, Yu DY, Cheong J, 2007: Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma[J]. Gastroenterology, 132, 1955-1967. doi: 10.1053/j.gastro.2007.03.039
-
Kock J, Rosler C, Zhang JJ, Blum HE, Nassal M, Thoma C, 2010: Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner[J]. PLoS Pathog, 6, e1001082-. doi: 10.1371/journal.ppat.1001082
-
Laplante M, Sabatini DM, 2012: mTOR signaling in growth control and disease[J]. Cell, 149, 274-293. doi: 10.1016/j.cell.2012.03.017
-
Lee DF, Kuo HP, Chen CT, Hsu JM, Chou CK, Wei Y, Sun HL, Li LY, Ping B, Huang WC, He X, Hung JY, Lai CC, Ding Q, Su JL, Yang JY, Sahin AA, Hortobagyi GN, Tsai FJ, Tsai CH, Hung MC, 2007: IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway[J]. Cell, 130, 440-455. doi: 10.1016/j.cell.2007.05.058
-
Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS, Jang KL, 2005: Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1[J]. Oncogene, 24, 6617-6625. doi: 10.1038/sj.onc.1208827
-
Lee SG, Rho HM, 2000: Transcriptional repression of the human p53 gene by hepatitis B viral X protein[J]. Oncogene, 19, 468-471. doi: 10.1038/sj.onc.1203312
-
Lekmine F, Sassano A, Uddin S, Smith J, Majchrzak B, Brachmann SM, Hay N, Fish EN, Platanias LC, 2004: Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein[J]. Exp Cell Res, 295, 173-182. doi: 10.1016/j.yexcr.2003.12.021
-
Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, Chen X, Wang Y, Tang H, 2015: The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment[J]. Sci Rep, 5, 8421-. doi: 10.1038/srep08421
-
Li J, Liu Y, Wang Z, Liu K, Wang Y, Liu J, Ding H, Yuan Z, 2011: Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment[J]. J Virol, 85, 6319-6333. doi: 10.1128/JVI.02627-10
-
Li Z, Xu G, Qin Y, Zhang C, Tang H, Yin Y, Xiang X, Li Y, Zhao J, Mulholland M, Zhang W, 2014: Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARgamma signaling pathway[J]. Proc Natl Acad Sci U S A, 111, 13163-13168. doi: 10.1073/pnas.1411571111
-
Liang TJ, Block TM, McMahon BJ, Ghany MG, Urban S, Guo JT, Locarnini S, Zoulim F, Chang KM, Lok AS, 2015: Present and future therapies of hepatitis B: from discovery to cure[J]. Hepatology, 62, 1893-1908. doi: 10.1002/hep.28025
-
Lin Y, Deng W, Pang J, Kemper T, Hu J, Yin J, Zhang J, Lu M, 2017: The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R/PI3K/Akt/mTOR/ULK1 signaling-induced autophagy[J]. Cell Microbiol, , -. doi: 10.1111/cmi.12709
-
Lin Y, Wu C, Wang X, Kemper T, Squire A, Gunzer M, Zhang J, Chen X, Lu M, 2019a: Hepatitis B virus is degraded by autophagosome-lysosome fusion mediated by Rab7 and related components[J]. Protein Cell, 10, 60-66. doi: 10.1007/s13238-018-0555-2
-
Lin Y, Wu C, Wang X, Liu S, Kemper T, Li F, Squire A, Zhu Y, Zhang J, Chen X, Lu M, 2019b: Synaptosomal-associated protein 29 is required for the autophagic degradation of hepatitis B virus[J]. FASEB J, 33, 6023-6034. doi: 10.1096/fj.201801995RR
-
Lin Y, Wu C, Wang X, Liu S, Zhao K, Kemper T, Yu H, Li M, Zhang J, Chen M, Zhu Y, Chen X, Lu M, 2019c: Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling[J]. Autophagy, 16, 568-516.
-
Lin Y, Zhao Z, Huang A, Lu M, 2020: Interplay between cellular autophagy and hepatitis B virus replication: a systematic review[J]. Cells, 9, 2101-. doi: 10.3390/cells9092101
-
Liu B, Fang M, He Z, Cui D, Jia S, Lin X, Xu X, Zhou T, Liu W, 2015: Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation[J]. Cell Death Dis, 6, e1980-. doi: 10.1038/cddis.2015.322
-
Liu H, Xu J, Zhou L, Yun X, Chen L, Wang S, Sun L, Wen Y, Gu J, 2011: Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway[J]. Cancer Res, 71, 7547-7557. doi: 10.1158/0008-5472.CAN-11-2260
-
Liu Y, Zhang DT, Liu XG, 2015: mTOR signaling in T cell immunity and autoimmunity[J]. Int Rev Immunol, 34, 50-66. doi: 10.3109/08830185.2014.933957
-
Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP, 2005: Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis[J]. Cell, 121, 179-193. doi: 10.1016/j.cell.2005.02.031
-
Mehta A, Lu X, Block TM, Blumberg BS, Dwek RA, 1997: Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion[J]. Proc Natl Acad Sci U S A, 94, 1822-1827. doi: 10.1073/pnas.94.5.1822
-
Na TY, Shin YK, Roh KJ, Kang SA, Hong I, Oh SJ, Seong JK, Park CK, Choi YL, Lee MO, 2009: Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma[J]. Hepatology, 49, 1122-1131. doi: 10.1002/hep.22740
-
Nassal M, 2015: HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B[J]. Gut, 64, 1972-1984. doi: 10.1136/gutjnl-2015-309809
-
Oehler N, Volz T, Bhadra OD, Kah J, Allweiss L, Giersch K, Bierwolf J, Riecken K, Pollok JM, Lohse AW, Fehse B, Petersen J, Urban S, Lutgehetmann M, Heeren J, Dandri M, 2014: Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism[J]. Hepatology, 60, 1483-1493. doi: 10.1002/hep.27159
-
Patman G, 2014: Hepatitis: HBV infection alters bile acid metabolism gene profile[J]. Nat Rev Gastroenterol Hepatol, 11, 332-.
-
Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG, Choi Y, 2009: Enhancing CD8 T-cell memory by modulating fatty acid metabolism[J]. Nature, 460, 103-107. doi: 10.1038/nature08097
-
Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, Guertin DA, Madden KL, Carpenter AE, Finck BN, Sabatini DM, 2011: mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway[J]. Cell, 146, 408-420. doi: 10.1016/j.cell.2011.06.034
-
Ranadheera C, Coombs KM, Kobasa D, 2018: Comprehending a killer: the Akt/mTOR signaling pathways are temporally high-jacked by the highly pathogenic 1918 Influenza Virus[J]. EBioMedicine, 32, 142-163. doi: 10.1016/j.ebiom.2018.05.027
-
Raney AK, Johnson JL, Palmer CN, McLachlan A, 1997: Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter[J]. J Virol, 71, 1058-1071. doi: 10.1128/jvi.71.2.1058-1071.1997
-
Rawat S, Bouchard MJ, 2015: The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival[J]. J Virol, 89, 999-1012. doi: 10.1128/JVI.02440-14
-
Reese V, Ondracek C, Rushing C, Li L, Oropeza CE, McLachlan A, 2011: Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development[J]. Int J Biochem Cell Biol, 43, 230-237. doi: 10.1016/j.biocel.2009.11.016
-
Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J, 2004: Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase[J]. Proc Natl Acad Sci U S A, 101, 13489-13494. doi: 10.1073/pnas.0405659101
-
Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM, 2004: Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton[J]. Curr Biol, 14, 1296-1302. doi: 10.1016/j.cub.2004.06.054
-
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, 2005: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex[J]. Science, 307, 1098-1101. doi: 10.1126/science.1106148
-
Saxton RA, Sabatini DM, 2017: mTOR signaling in growth, metabolism, and disease[J]. Cell, 168, 960-976. doi: 10.1016/j.cell.2017.02.004
-
Semenza GL, 2010: HIF-1: upstream and downstream of cancer metabolism[J]. Curr Opin Genet Dev, 20, 51-56. doi: 10.1016/j.gde.2009.10.009
-
Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM, 2010: mTORC1 controls fasting-induced ketogenesis and its modulation by ageing[J]. Nature, 468, 1100-1104. doi: 10.1038/nature09584
-
Shimobayashi M, Hall MN, 2014: Making new contacts: the mTOR network in metabolism and signalling crosstalk[J]. Nat Rev Mol Cell Biol, 15, 155-162. doi: 10.1038/nrm3757
-
Shin HJ, Park YH, Kim SU, Moon HB, Park DS, Han YH, Lee CH, Lee DS, Song IS, Lee DH, Kim M, Kim NS, Kim DG, Kim JM, Kim SK, Kim YN, Kim SS, Choi CS, Kim YB, Yu DY, 2011: Hepatitis B virus X protein regulates hepatic glucose homeostasis via activation of inducible nitric oxide synthase[J]. J Biol Chem, 286, 29872-29881. doi: 10.1074/jbc.M111.259978
-
Shlomai A, Paran N, Shaul Y, 2006: PGC-1alpha controls hepatitis B virus through nutritional signals[J]. Proc Natl Acad Sci U S A, 103, 16003-16008. doi: 10.1073/pnas.0607837103
-
Shlomai A, Shaul Y, 2009: The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription[J]. Biochem Biophys Res Commun, 381, 544-548. doi: 10.1016/j.bbrc.2009.02.078
-
Sigrid Schmitt DG, Alving K, Tolle TK, Linder M, Geyer H, Linder D, Peter-Katalinic J, Gerlich WH, Geyeri R, 1999: Analysis of the Pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus[J]. J Biol Chem, 274, 11945-11957. doi: 10.1074/jbc.274.17.11945
-
Sir D, Tian Y, Chen WL, Ann DK, Yen TS, Ou JH, 2010: The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication[J]. Proc Natl Acad Sci U S A, 107, 4383-4388. doi: 10.1073/pnas.0911373107
-
Subic M, Zoulim F, 2018: How to improve access to therapy in hepatitis B patients[J]. Liver Int, 38, 115-121.
-
Tang LSY, Covert E, Wilson E, Kottilil S, 2018: Chronic hepatitis B infection: A review[J]. JAMA, 319, 1802-1813. doi: 10.1001/jama.2018.3795
-
Tarn C, Lee S, Hu Y, Ashendel C, Andrisani OM, 2001: Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes[J]. J Biol Chem, 276, 34671-34680. doi: 10.1074/jbc.M104105200
-
Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J, 2003: Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb[J]. Curr Biol, 13, 1259-1268. doi: 10.1016/S0960-9822(03)00506-2
-
Teng CF, Hsieh WC, Wu HC, Lin YJ, Tsai HW, Huang W, Su IJ, 2015a: Hepatitis B virus pre-S2 mutant induces aerobic glycolysis through mammalian target of rapamycin signal cascade[J]. PLoS ONE, 10, e0122373-. doi: 10.1371/journal.pone.0122373
-
Teng CF, Wu HC, Hsieh WC, Tsai HW, Su IJ, 2015b: Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis[J]. J Virol, 89, 605-614. doi: 10.1128/JVI.02363-14
-
Teng CF, Wu HC, Tsai HW, Shiah HS, Huang W, Su IJ, 2011: Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy[J]. Hepatology, 54, 1199-1207. doi: 10.1002/hep.24529
-
Tian Y, Sir D, Kuo CF, Ann DK, Ou JH, 2011: Autophagy required for hepatitis B virus replication in transgenic mice[J]. J Virol, 85, 13453-13456. doi: 10.1128/JVI.06064-11
-
Tong S, Revill P, 2016: Overview of hepatitis B viral replication and genetic variability[J]. J Hepatol, 64, S4-16. doi: 10.1016/j.jhep.2016.01.027
-
Uddin S, Yenush L, Sun XJ, Sweet ME, White MF, Platanias LC, 1995: Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3'-kinase[J]. J Biol Chem, 270, 15938-15941. doi: 10.1074/jbc.270.27.15938
-
Wang BT, Ducker GS, Barczak AJ, Barbeau R, Erle DJ, Shokat KM, 2011: The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile[J]. Proc Natl Acad Sci U S A, 108, 15201-15206. doi: 10.1073/pnas.1103746108
-
Wang F, Alain T, Szretter KJ, Stephenson K, Pol JG, Atherton MJ, Hoang HD, Fonseca BD, Zakaria C, Chen L, Rangwala Z, Hesch A, Chan ESY, Tuinman C, Suthar MS, Jiang Z, Ashkar AA, Thomas G, Kozma SC, Gale M Jr, Fitzgerald KA, Diamond MS, Mossman K, Sonenberg N, Wan Y, Lichty BD, 2016: S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3[J]. Nat Immunol, 17, 514-522. doi: 10.1038/ni.3433
-
Wang HC, Wu HC, Chen CF, Fausto N, Lei HY, Su IJ, 2003: Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress[J]. Am J Pathol, 163, 2441-2449. doi: 10.1016/S0002-9440(10)63599-7
-
Wang HY, Yang SL, Liang HF, Li CH, 2014: HBx protein promotes oval cell proliferation by up-regulation of cyclin D1 via activation of the MEK/ERK and PI3K/Akt pathways[J]. Int J Mol Sci, 15, 3507-3518. doi: 10.3390/ijms15033507
-
Wang J, Chen J, Liu Y, Zeng X, Wei M, Wu S, Xiong Q, Song F, Yuan X, Xiao Y, Cao Y, Li C, Chen L, Guo M, Shi YB, Sun G, Guo D, 2019: Hepatitis B Virus Induces Autophagy to Promote its Replication by the Axis of miR-192-3p-XIAP Through NF kappa B Signaling[J]. Hepatology, 69, 974-992. doi: 10.1002/hep.30248
-
Wang M, Qiu N, Lu S, Xiu D, Yu J, Wang XT, Lu F, Li T, Liu X, Zhuang H, 2013: Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naive patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma[J]. J Med Virol, 85, 219-227. doi: 10.1002/jmv.23461
-
Wang P, Guo QS, Wang ZW, Qian HX, 2013: HBx induces HepG-2 cells autophagy through PI3K/Akt-mTOR pathway[J]. Mol Cell Biochem, 372, 161-168. doi: 10.1007/s11010-012-1457-x
-
Wang X, Huo B, Liu J, Huang X, Zhang S, Feng T, 2019: Hepatitis B virus X reduces hepatocyte apoptosis and promotes cell cycle progression through the Akt/mTOR pathway in vivo[J]. Gene, 691, 87-95. doi: 10.1016/j.gene.2018.12.054
-
Wang X, Lin Y, Kemper T, Chen J, Yuan Z, Liu S, Zhu Y, Broering R, Lu M, 2020a: AMPK and Akt/mTOR signalling pathways participate in glucose-mediated regulation of hepatitis B virus replication and cellular autophagy[J]. Cell Microbiol, 22, e13131-.
-
Wang X, Lin Y, Liu S, Zhu Y, Lu K, Broering R, Lu M, 2020b: O-GlcNAcylation modulates HBV replication through regulating cellular autophagy at multiple levels[J]. FASEB J, 34, 14473-14489. doi: 10.1096/fj.202001168RR
-
Wang X, Wei Z, Lan T, He Y, Cheng B, Li R, Chen H, Li F, Liu G, Jiang B, Lin Y, Lu M, Meng Z, 2021: CCDC88A/GIV promotes HBV replication and progeny secretion via enhancing endosomal trafficking and blocking autophagic degradation[J]. Autophagy, 1934271, 1-18. doi: 10.1080/15548627.2021.1934271:1-18
-
Weichhart T, Hengstschlager M, Linke M, 2015: Regulation of innate immune cell function by mTOR[J]. Nat Rev Immunol, 15, 599-614. doi: 10.1038/nri3901
-
Weng L, Enomoto A, Miyoshi H, Takahashi K, Asai N, Morone N, Jiang P, An J, Kato T, Kuroda K, Watanabe T, Asai M, Ishida-Takagishi M, Murakumo Y, Nakashima H, Kaibuchi K, Takahashi M, 2014: Regulation of cargo-selective endocytosis by dynamin 2 GTPase-activating protein girdin[J]. EMBO J, 33, 2098-2112. doi: 10.15252/embj.201488289
-
Wong VW, Wong GL, Chu WC, Chim AM, Ong A, Yeung DK, Yiu KK, Chu SH, Chan HY, Woo J, Chan FK, Chan HL, 2012: Hepatitis B virus infection and fatty liver in the general population[J]. J Hepatol, 56, 533-540. doi: 10.1016/j.jhep.2011.09.013
-
Wullschleger S, Loewith R, Hall MN, 2006: TOR signaling in growth and metabolism[J]. Cell, 124, 471-484. doi: 10.1016/j.cell.2006.01.016
-
Xiang K, Wang B, 2018: Role of the PI3K/AKT/mTOR pathway in hepatitis B virus infection and replication[J]. Mol Med Rep, 17, 4713-4719.
-
Xie N, Yuan K, Zhou L, Wang K, Chen HN, Lei Y, Lan J, Pu Q, Gao W, Zhang L, Shen G, Li Q, Xiao H, Tang H, Xiang R, He M, Feng P, Nice EC, Wei Y, Zhang H, Yang J, Huang C, 2016: PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation[J]. Autophagy, 12, 1507-1520. doi: 10.1080/15548627.2016.1191857
-
Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, Ding L, Zhang H, Cheng L, Fu H, Song Y, Jiang Y, Liu J, Wang R, Du N, Ye Q, 2013: Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis[J]. J Clin Invest, 123, 630-645.
-
Yan H, Peng B, Liu Y, Xu G, He W, Ren B, Jing Z, Sui J, Li W, 2014: Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide[J]. J Virol, 88, 3273-3284. doi: 10.1128/JVI.03478-13
-
Yang F, Yan S, He Y, Wang F, Song S, Guo Y, Zhou Q, Wang Y, Lin Z, Yang Y, Zhang W, Sun S, 2008: Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver[J]. J Hepatol, 48, 12-19. doi: 10.1016/j.jhep.2007.06.021
-
Yang JC, Teng CF, Wu HC, Tsai HW, Chuang HC, Tsai TF, Hsu YH, Huang W, Wu LW, Su IJ, 2009: Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis[J]. Hepatology, 49, 1962-1971. doi: 10.1002/hep.22889
-
Yen CJ, Lin YJ, Yen CS, Tsai HW, Tsai TF, Chang KY, Huang WC, Lin PW, Chiang CW, Chang TT, 2012: Hepatitis B virus X protein upregulates mTOR signaling through IKKbeta to increase cell proliferation and VEGF production in hepatocellular carcinoma[J]. PLoS ONE, 7, e41931-. doi: 10.1371/journal.pone.0041931
-
Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, Roggendorf M, Lu M, 2011: Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1[J]. Hepatology, 53, 1476-1485. doi: 10.1002/hep.24195
-
Zhou J, Tan SH, Nicolas V, Bauvy C, Yang ND, Zhang J, Xue Y, Codogno P, Shen HM, 2013: Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion[J]. Cell Res, 23, 508-523. doi: 10.1038/cr.2013.11
-
Zhu M, Guo J, Li W, Xia H, Lu Y, Dong X, Chen Y, Xie X, Fu S, Li M, 2015: HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells[J]. BMC Cancer, 15, 362-. doi: 10.1186/s12885-015-1384-9
-
Zhu M, Li W, Lu Y, Dong X, Lin B, Chen Y, Zhang X, Guo J, Li M, 2017: HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway[J]. Int J Cancer, 140, 1346-1355. doi: 10.1002/ijc.30553